Paper Details

  1. Home
  2. Paper Details

New formulation of aqueous flunisolide nasal spray in the treatment of allergic rhinitis: comparative assessment of safety, tolerability, and efficacy.

Author: BynumL, GrossG, MunshiA, RatnerP, van BavelJ

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study compared a new formulation of flunisolide nasal spray with the original formulation in the treatment of allergic rhinitis. Both formulations were comparable in efficacy, but the new formulation was better tolerated.
Paper Details　
Original Abstract of the Article :
This 6-week, multicenter, double-blind, randomized, placebo-controlled, parallel-group trial compared the safety, efficacy, and tolerability of a new formulation of flunisolide nasal spray with the original formulation in the treatment of allergic rhinitis due to mountain cedar pollenosis. It was co...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2500/108854196779165049

データ提供：米国国立医学図書館（NLM）

A New Formulation for Allergic Rhinitis: Improved Tolerability

Allergic rhinitis, a common condition characterized by nasal inflammation, can be a significant burden for sufferers. This study explores the efficacy and tolerability of a new formulation of flunisolide nasal spray compared to the original formulation for treating allergic rhinitis due to mountain cedar pollenosis. This study highlights the importance of developing improved formulations of medications to enhance patient compliance and optimize treatment outcomes.

Comparing the Efficacy and Tolerability of Flunisolide Formulations

The study found that the new formulation of flunisolide nasal spray was comparable in efficacy to the original formulation in relieving allergic rhinitis symptoms. However, the new formulation was significantly better tolerated, with fewer patients reporting nasal burning and stinging. These findings suggest that the new formulation may improve patient compliance and satisfaction with treatment.

Developing Patient-Centered Treatment Options

This research highlights the importance of developing patient-centered treatment options for allergic rhinitis, taking into account both efficacy and tolerability. The findings suggest that the new formulation of flunisolide nasal spray may offer a more favorable treatment option for some patients, potentially leading to improved compliance and better overall outcomes. This research encourages further exploration of new and improved formulations of medications, with a focus on enhancing patient comfort and satisfaction.

Dr. Camel's Conclusion

This study is a testament to the continuous evolution of medical treatment options. The development of a new and improved formulation of flunisolide nasal spray highlights the dedication of researchers in seeking better and more tolerable treatments for common conditions like allergic rhinitis. This research reminds us that the quest for optimal medical solutions is an ongoing journey, driven by a commitment to improving patient outcomes and enhancing the quality of life for all.

Date :
  1. Date Completed 1997-04-09
  2. Date Revised 2021-09-01
Further Info :

Pubmed ID

8790827

DOI: Digital Object Identifier

10.2500/108854196779165049

Related Literature

Article Analysis
・Effects of flunisolide nasal spray
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.